United States Tasigna Market Report 2017

United States Tasigna Market Report 2017

  • QYResearch
  • August 2017
  • Pharmaceutical
  • 98 pages

Report Description

In this report, the United States Tasigna market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Tasigna in these regions, from 2012 to 2022 (forecast).

United States Tasigna market competition by top manufacturers/players, with Tasigna sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis Pharma
Harbin Pharmaceutical Group

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
200 mg Capsule
150 mg Capsule
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Tasigna for each application, including

Have query on this report?

Make an Enquiry
Table of Contents
United States Tasigna Market Report 2017
1 Tasigna Overview
1.1 Product Overview and Scope of Tasigna
1.2 Classification of Tasigna by Product Category
List of Tables and Figures
Figure Product Picture of Tasigna
Figure United States Tasigna Market Size (K Units) by Type (2012-2022)
Figure United States Tasigna Sales Volume Market Share by Type (Product Category) in 2016
Figure 200 mg Capsule Product Picture
Figure 150 mg Capsule Product Picture

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.


get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074